Background: Fatigue is common after traumatic brain injury (TBI). Its risk factors, natural history and consequences are uncertain. Best-evidence synthesis was used to address the gaps. Methods: Five databases were searched for relevant peer-reviewed studies. Of the 33 articles appraised, 22 longitudinal studies were selected. Results were reported separately based on their timing of baseline assessment.
Background
Traumatic brain injury (TBI), defined as "an alteration in brain function, or other evidence of brain pathology, caused by an external force" (Brain Injury Association of America, 2013) , is among the most serious, disabling neurological disorders in all societies and expected to rank as the major cause of death and disability by the year 2020 (World Health Organization, 2002) . Over the past decades, evidence has emerged citing fatigue as a common, longlasting problem after TBI (Belmont et al., 2006; Ponsford et al., 2011; Middleboe et al., 1992) . It is burdensome to patients, and is associated with poor outcomes (Belmont et al., 2006; Ponsford et al., 2011) . In a number of studies, over half of the patients making up the TBI samples reported fatigue's negative effect on social, physical and cognitive functioning (Ziino and Ponsford, 2006) and participation in everyday activities (Cantor et al., 2008) , and role in increased work-related and other disabilities (McCrimmon and Oddy, 2006) . Estimates of the incidence of fatigue after TBI vary from 21% to 73%, depending on the characteristics of the studied population (e.g. severity of injury, time since injury, sampling of patients, etc.) and the method used to identify fatigue (e.g. single item or fatigue scales) (Belmont et al., 2006; Ponsford et al., 2011; Middleboe et al., 1992; Borgaro et al., 2005; Lidvall et al., 1974 ).
The term "fatigue" has several meanings. It is recognized when performance of an activity results in diminished capacity for carrying out a function (Chaudhuri and Behan, 2004) . Within this, 'physiological fatigue' refers to the state of general tiredness due to physical or mental exertion, which can be ameliorated by rest (Schillings et al., 2007) . A state that refers to a weariness unrelated to previous exertion level, and not ameliorated by rest, is termed 'pathological fatigue' . Despite such characterization, fatigue in the TBI population is difficult to elucidate. This is partly due to the numerous plausible biological causes of fatigue (i.e. neuroanatomical, functional, psychological/psychiatric, biochemical, endocrine, sleep-related) , independently or combined, through which this symptom can evolve after brain injury ( Fig. 1 ) (Prins et al., 2006) . To date, several narrative reviews have been published to provide insight into the topic of post-traumatic fatigue (PTF) (Belmont et al., 2006; Borgaro et al., 2005; Ponsford et al., 2012; Levine and Greenwald, 2009) . Nevertheless, there is still little known about which specific clinical, behavioral and physiological factors are associated with its occurrence after brain injury; nor whether fatigue remains the same in its frequency/intensity, or changes over time. Finally, the overall health burden of this symptom in the TBI population remains uncertain. Understanding the facets of fatigue in TBI can guide in differential diagnosis Modified from Chaudhuri and Behan (2004) , Finsterer and Mahjoub (2013) and Kluger et al. (2013) .
and follow-up treatments. Moreover, identifying the most important contributors to PTF can change the view on the interventions necessary to deal with this significant symptom. This systematic review was performed with the following goals, all with respect to patients with TBI: (1) to determine the prognostic factors associated with fatigue onset; (2) to describe the course of fatigue; and (3) to describe the health consequences of fatigue.
Methods/design

Data sources and searches
This review was conducted and reported in compliance with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines (Moher et al., 2009 ). The systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (Mollayeva et al., 2013a) on April 25, 2013 (registration number CRD42013004262) .
In collaboration with disease experts and a medical information specialist, we developed a comprehensive search strategy for studying fatigue in TBI (Mollayeva et al., 2013a) . All English language peer-reviewed studies with prospective or retrospective data collection and a longitudinal design, found through PsycINFO, MED-LINE, EMBASE and CINAHL, published since 1806 , 1946 , 1974 and 1980 , respectively, were eligible. Cochrane Database of Systematic Reviews was also searched for studies published between 2005 and early April 2013. Publications identified from bibliographies of identified articles and reviews were considered eligible. The basic search can be found in Supplementary File 1. For the complete search strategy, we refer the reader to the published protocol (Mollayeva et al., 2013a) .
Inclusion criteria
Peer-reviewed, English language studies that investigated fatigue in adult patients with a diagnosis of TBI and followed them for any period were included. Studies that focused on a different but parallel topic to fatigue (e.g. sleepiness, impaired alertness, or vigilance) and studies about fatigue after brain injury due to secondary pathological processes (e.g. edema, intracranial hemorrhages, ischemia/infarction, and systemic intracranial conditions) were excluded. Further, case reports, pediatric studies, dissertations, and articles with no primary data were excluded. For more information, we refer the reader to the protocol (Mollayeva et al., 2013a) .
Study design
All experimental intervention and effectiveness studies of longitudinal design and observational cohort-and case control-designed studies were considered for this review.
Study review
In the first stage of screening, two reviewers (TM and TK or TM and SM) assessed study titles and abstracts for possible agreement with the inclusion criteria. In the second stage, each reviewer individually assessed the full text of articles selected in the first stage to determine whether they met inclusion criteria. Differences of opinion were resolved by discussion between reviewers, or by seeking advice from other experts (AC, CS, and JDC). Studies failing to meet the inclusion criteria were excluded, with reasons listed in Supplementary file 2.
Data extraction and quality assessment
The abstracted data included: (1) study characteristics (i.e. author names, publication year, country, setting, design, sample size, methods of measuring fatigue, and other variables [e.g. factors], number of participants assessed at each time point, time between assessments, and time from injury to follow-up); (2) participant characteristics (i.e. mean age, sex, definition of TBI, localization of injury, and injury severity); (3) medications used by or administered to participants; and (4) results (i.e. reported frequencies of fatigue and other factors, and reported associations between fatigue and other variables) (Tables 1-3) .
For studies that fulfilled the inclusion criteria, two reviewers (TM and TK) independently extracted data into data collection forms grouped according to study design. The observational studies' data were used to address the three research objectives (i.e. prognostic factors, course of fatigue, and consequences). Randomized control trials (RCTs) were treated as cohorts, and the control Socialization: 24 ± 14; 20 ± 13; 22 ± 15 Mental functioning: 25 ± 12; 20 ± 12; 21 ± 12 General impact: 11 ± 7; 9 ± 6; 10 ± 6 Relieving factors: 16 ± 8; 15 ± 8; 18 ± 6 Aggravating factors: 21 ± 14; 18 ± 11; 21 ± 10 GFI (n = 43*): 23 ± 10; 17 ± 11; 20 ± 11 FSS (n = 45*): 3.4 ± 1.5; 2.9 ± 1.6; 3.2 ± 1.8 *Missing data, unanswered questions 1: t1, t2: total (74.8 ± 20.4, 48.5 ± 20.9); general (17.2 ± 4.0, 9.8 ± 4.8); physical (16 ± 6.2, 10 ± 3.5); mental (17.2 ± 3.3, 10.3 ± 6.3); reduced activity (14.3 ± 5.6, 11.3 ± 5.4); reduced motivation (10.2 ± 4.8, 7 ± 2.8) 2: t1, t2: total (61.5 ± 18.9, 61.3 ± 20.6); general (14.8 ± 4.2, 14 ± 4.6); physical (10.5 ± 4.5, 10.8 ± 5.3); mental (15.5 ± 3.8, 15.7 ± 3.5); reduced activity (10.7 ± 4.7, 10.8 ± 5.3); reduced motivation (10 ± 3.9, 10 ± 4.9) Stratified MFI scores by time-point: Pre-tx: total (68.1 ± 20.8); general (15.6 ± 4.4); physical (13.4 ± 6.2); mental (16.4 ± 3.3); reduced activity (12.6 ± 5.4); reduced motivation (10.1 ± 4.6) Post-tx: total (50.1 ± 19.0); general (11.2 ± 4.8); physical (9.8 ± 3.3); mental (11 ± 4.9); reduced activity (10.1 ± 4.8); reduced motivation (8 ± 3.6) F/U: total (47.3 ± 20.0); general (10.5 ± 5.1); physical (9.3 ± 5.0); mental (10.7 ± 4.4); reduced activity (8 ± 4.2); reduced motivation (7.7 ± 4.4) Between-group comparison of MFI scores: total (F = 3.68, p < .1); general (F = 8.04, p < .05); physical (F = 2.88); mental (F = 9.10, p < .05); reduced activity (F = .24); reduced motivation (F = 1.99) Changes in MFI scores: total (F = 8.43, p < .01); general (F = 6.5, p < .01); physical (F = 4.02, p < .05); mental (F = 14.68, p < .001); reduced activity (F = 3.48, p < .1); reduced motivation (F = 2.72, p < .1) Significant differences (p < .05): Pre-post, F/U: total, general, mental Predictor of severity at 3 mos • Severity at wk 1 (FSS) (R = 0.53; p < .000) Predictor of severity at 6 mos • Severity at wk 1 (R = 0.49; p < .000)
• Severity at 3 mos (R = 0.76; p < .000)
• Depression at 3 mos (B = .12; SE = .04; ˇ = .25; p < .0000)
• Anxiety at 3 mos (B = −.01; SE = .03; ˇ = −.04; p = .610) Sundstrom et al. (2007) Fatigue question • Frequency measure (i.e. answer "yes" to question "Do you often feel fatigued?" indicates fatigue)
Predictor of frequency post-injury
• APOE 4 genotype (p = .02) APOE 4, apolipoprotein-4; MOS SF-36v2 NS, not significant -36-item short form health survey vitality subscale (from medical outcomes study); FSS, fatigue severity scale; RPQ, Rivermead post-concussive questionnaire; wk, week.
(i.e. untreated group) data and no effect data (i.e. intervention has not effect) were utilized to address the second research objective (i.e. to determine the course of fatigue) in patients with TBI. Study quality was independently assessed by two reviewers (TM and TK), using guidelines developed by Hayden et al. (2006) for assessment of prognostic studies (Table 4 ). The appraisal was performed in two steps. First, the items related to six potential sources of bias (i.e. study participation and attrition, associated factors and outcome measurements, confounding measurement, and analyses) were assessed, then presence of potential biases was judged "Yes", "Partly", "No", or "Unsure". To summarize the level of evidence, we used a system similar to the Scottish Intercollegiate Guidelines Network (SIGN) methodology (SIGNPG, 2013): (i) "+++" when all or most of the quality criteria proposed by Hayden et al. were fulfilled (i.e. allowing one "Partly" while appraising all potential sources of bias); (ii) "++" when the majority of criteria were fulfilled; (iii) "+" when few criteria were fulfilled (i.e. at least one "Yes"). Additionally, as proposed by SIGN, studies with retrospective data collection did not receive a "++" rating, as this design is weaker than prospective data collection. We refer to group (i) as 'high quality studies'; group (ii) as 'good quality studies'; and group (iii) as 'fair quality studies'.
Data synthesis
A best-evidence synthesis approach was applied, synthesizing findings from studies with sufficient quality through tabulation and qualitative description (Slavin, 1995; Carroll et al., 2004a) .
Results were grouped into three main categories: prognostic factors of fatigue, course of the fatigue, and consequences of fatigue (Tables 1-3 ). For studies utilizing measures of fatigue prevalence, sample size-weighted mean frequencies were reported. Fatigue severity measures used in the studies were reported with their corresponding sample mean scores. To determine the course of fatigue, matching assessment times (i.e. time post-injury that fatigue was measured) were grouped, with their corresponding fatigue frequencies, and a sample size-weighted mean frequency value was calculated for time points with more than one contributing frequency value (i.e. more than one study reporting fatigue at that time point). Fatigue resolution/exacerbation/no change designations were reported.
Prognostic factors associated with fatigue were extracted for all cohorts and untreated/no effect RCTs. All factors influencing the course of fatigue, as reported by authors, were considered associated with fatigue and not necessarily causal factors. To address our third research objective (i.e. health consequences of fatigue in TBI), we evaluated reports of poor health outcomes associated with fatigue after TBI.
Zero-time
The nature of our research questions related to fatigue in the TBI population (i.e. prognostic factors, course, and consequences) raises the issue of zero-time bias. In prognostic studies, testing should start at a defined point, called zero time (Giobbie-Hurder et al., 2013; van Rein et al., 2014) . Designated zero times (i.e. baseline or first assessment) varied between studies included in this review. For this reason and to best address our research questions, studies were grouped based on whether baseline assessments were conducted before or after the one-month post-injury mark. This point was arbitrarily set.
Missing data
Primary authors were contacted in the case of missing data. In the case of duplicate publications and companion papers of a primary study, we attempted to maximize the yield of information by the simultaneous evaluation of all available data (i.e. all data necessary to address the three objectives of research, see Section 2.5).
Original publications took priority.
Results
Literature search and quality assessment
Of 2745 articles identified, 33 were selected for full-text review Ponsford et al., 2012; 
Articles assessed for e ligibility (i.e. reading full tex t) (n=8 9)
Excluded based on inclusion criteria (N=56): n ot refereed (n=21), no measu re of fatigue (n= 16), stud y design (i.e. no t lon gitudinal) (n=9), no separate analysis of TBI patients (n= 5); foc us on differen t construct (i.e. apathy, sleepine ss, etc.) (n= 5)
Articles to next round (n= 33)
Excluded based on quality a ssessmen t (n=6) Inabilit y to obtain information after contacting author(s) (n=3) Same population in multiple studies (i.e. quality ("++") and the remaining 14 Yang et al., 2009; Hutchinson et al., 2009; Sigurdardottir et al., 2009; Kempf et al., 2010; Driver and Ede, 2009; Gemmell and Leathem, 2006; Jha et al., 2008; Kaiser et al., 2010; Khateb et al., 2005; Schoenberger et al., 2001; Bushnik et al., 2008b) were of fair quality ("+"). The latter group were penalized by the SIGN criteria (SIGNPG, 2013) for incomplete statistical analysis, potential confounders, selection bias due to study attrition, and/or zero-time bias (Table 4) .
Study characteristics
Tables 2-4 summarize the study characteristics pertinent to our research questions: population characteristics, definitions of TBI, definitions of fatigue, follow-up time, statistical analysis methods, and study results. Means were calculated for the reviewed studies' sample data.
Studies with baseline assessment up to one month post-injury
Eleven studies featured a total of 1366 participants with TBI. Nine studies performed recruitment at emergency departments, hospitals, or trauma centers, making up 91% of the total group (n = 1244) Ponsford et al., 2012; De Leon et al., 2009; Lundin et al., 2006; Meares et al., 2011; Mickeviciene et al., 2004; Norrie et al., 2010; van der Naalt et al., 1999; Yang et al., 2009) . One study recruited participants from the community (7.5% of the sample, or n = 102) . One study featured university athletes within four days of concussion, making up 1.5% of the sample (n = 20) .
Nine studies featured strictly participants with mild TBI Ponsford et al., 2012; De Leon et al., 2009; Lundin et al., 2006; Meares et al., 2011; Mickeviciene et al., 2004; Norrie et al., 2010; Yang et al., 2009) , one examined mild to moderate TBI (van der Naalt et al., 1999), and one included all TBI severities .
The study samples comprised males in a range between 42% (De ) and 69% , with a mean 62.1 ± 9.5% across studies. One study did not report a sex ratio, stating the sample consisted mainly of single males, and was included in the mean calculation as 75% male . The mean age ranged between 20.1 and 41.2 years of age , with a mean 33.5 ± 5.6 years across studies. Mean time since injury (TSI) to baseline assessment ranged from one day to one month , and the mean TSI across all studies was 0.34 ± 0.38 months, or 10.2 ± 11.4 days.
Studies with baseline assessment after one month post-injury
Eleven studies Sigurdardottir et al., 2009; Kempf et al., 2010; Driver and Ede, 2009; Gemmell and Leathem, 2006; Bushnik et al., 2008a; Jha et al., 2008; Kaiser et al., 2010; Khateb et al., 2005; Schoenberger et al., 2001; Hou et al., 2012 ) featured a total 482 participants. Eight of these studies recruited from the community, making up 43.4% of the total group (i.e. n = 209) Sigurdardottir et al., 2009; Kempf et al., 2010; Driver and Ede, 2009; Gemmell and Leathem, 2006; Bushnik et al., 2008a; Kaiser et al., 2010; Schoenberger et al., 2001) . Bushnik et al. (2008a) Gemmell and Leathem, 2006; Jha et al., 2008; Kaiser et al., 2010; Schoenberger et al., 2001) , two comprised patients with moderate to severe TBI Khateb et al., 2005) , and two with mild TBI Hou et al., 2012) .
The percentage of males ranged between 17% ) and 85% , with a mean 62 ± 19.2% across samples. The mean age ranged from 31 years to 55.2 years of age , with a mean 39.9 ± 6.6 years across studies. Mean TSI, across the ten studies, was 39.5 ± 35.5 months (i.e. 1185 ± 1065 days) and baseline assessment times ranged from 2.6 months ) to 8.6 years post-injury (Gemmell and Leathem, 2006) .
Assessment of TBI
Considerable between-study variation was observed in TBI diagnostic criteria and definitions, irrespective of TSI at baseline assessment (Tables 1-3 ). Most studies (17/22) used a combinatorial approach to confirm and assess TBI, using tools such as the Glasgow Coma Scale (GCS), duration of posttraumatic amnesia (PTA) and loss of consciousness (LOC), and clinical evaluation Ponsford et al., 2012; De Leon et al., 2009; Lundin et al., 2006; Meares et al., 2011; Mickeviciene et al., 2004; Norrie et al., 2010; van der Naalt et al., 1999; Yang et al., 2009; McLean et al., 1993; Hutchinson et al., 2009; Sigurdardottir et al., 2009; Gemmell and Leathem, 2006; Bushnik et al., 2008a; Jha et al., 2008; Khateb et al., 2005; Hou et al., 2012) . Three studies Driver and Ede, 2009; Schoenberger et al., 2001 ) used other methods, including patient report, description of damage and/or lesions based on medical records, and diagnoses of referring professionals. Two studies used GCS scores alone Kaiser et al., 2010) .
Methods used for assessing fatigue
Measures used to assess fatigue in the TBI population varied depending on the study objectives. Studies where fatigue was not a main focus most commonly used a single item for the symptom within a checklist with broad symptom coverage (9/22) (e.g. Rivermead post-concussion questionnaire (RPQ) and the postconcussion syndrome checklist (PCSC)) (Tables 2 and 3). If fatigue was studied more extensively, standardized measures looking at different aspects of the symptom, such as momentary perception, chronic characteristics, impact of fatigue on function, rating/rank of fatigue intensity/severity and dimensions of fatigue (i.e. cognitive, physical) were utilized. Four of the 22 studies used more than one measure to assess fatigue. All fatigue scales were designed for other populations, with some having psychometric properties described in the TBI population (Supplementary file 3) .
Multi-item scales
Most studies (14/22) assessed fatigue based on standardized self-report measures -four used the fatigue severity scale (FSS) Kempf et al., 2010; Jha et al., 2008; Kaiser et al., 2010) ; four -the short-form health survey-36 (SF-36) vitality subscale De Leon et al., 2009; Norrie et al., 2010; Gemmell and Leathem, 2006) ; two -a visual analog scale (VAS) for fatigue Gemmell and Leathem, 2006) , and two -the profile of mood states (POMS) fatigue-inertia scale Driver and Ede, 2009) . One study assessed fatigue with the Barroso fatigue scale (BFS), a synthesis of five independent scales, with additions . The BFS yields FSS and global fatigue index (GFI) scores. One study utilized the modified fatigue impact scale (MFIS) , one used the fatigue assessment inventory , and one again used the multidimensional fatigue inventory . We refer the reader to Supplementary file 3 for descriptions of measures.
On the FSS, participants rate their level of agreement with respect to nine statements about the severity of fatigue and its impact on everyday activities (Krupp et al., 1989) . The total score is the mean, and higher scores indicate greater fatigue. In some cases, studies reported frequency of fatigue by the FSS, defining presence of the symptom as a total score ≥4 Kaiser et al., 2010) , or ≥3.7 . Others used FSS scores as indicators of fatigue severity Bushnik et al., 2008a; Jha et al., 2008) .
On the four-item SF-36 vitality subscale, participants choose, on a six-point scale, the frequency of events related to fatigue and energy (Ware, 1992) . Fatigue item means are combined with reverse-scored energy means to yield a total score. Two studies utilized two different versions of the measure (i.e. SF-36 and SF-36 version 2). SF-36 and the updated SF-36 version 2 are comparable in terms of scores.
Single item assessment of fatigue
Nine papers used a single item or question to assess fatigue Ponsford et al., 2012; Lundin et al., 2006; Meares et al., 2011; van der Naalt et al., 1999; Yang et al., 2009; McLean et al., 1993; Sundstrom et al., 2007; Hou et al., 2012) , presenting TBI patients with a list of symptoms (e.g. Rivermead PCSQ, PCS checklist, etc.), including fatigue. One study determined presence of fatigue by participants' 'Yes' responses to the question, "Do you often feel fatigued?" .
Multiple measures of fatigue
Four studies used more than one measure to assess fatigue Norrie et al., 2010; Gemmell and Leathem, 2006; Jha et al., 2008) . Gemmell and Leathem (2006) utilized the SF-36 vitality subscale with the VAS for fatigue, for a measure of fatigue severity. Jha et al. (2008) worked with the FSS and MFIS and reported change in severity of fatigue with use of medications. Norrie et al. (2010) utilized the SF-36 vitality subscale with the RPQ for severity and frequency values. The SF-36 vitality subscale was used again by Ponsford et al. (2012) together with a single item from the PCS checklist, to report frequency and severity of fatigue across time.
Overall predictors of fatigue
Only studies with baseline assessment prior to one month postinjury investigated predictors of fatigue. All statistically significant predictors of fatigue identified are reported in Table 2 . Three studies, one of high quality and two of moderate quality Norrie et al., 2010; Sundstrom et al., 2007) identified eight factors significantly associated with fatigue in TBI patients (Table 3) . The factors comprised earlier fatigue severity, significant in two studies Norrie et al., 2010) , carriage of the apolipoprotein E 4 allele, significant in one study , having seen a counselor for a mental health issue, medical disability, marital status (i.e. widowed, divorced, or separated) and litigation involvement, all significant in one study , and depression, also significant in one study . One moderate quality study did not find a significant effect of sex, education, or TBI type/severity on fatigue in a fully adjusted model . In that same study, anxiety at three months was not a predictor of fatigue at six months .
The course of fatigue
Mean frequencies of fatigue at time points with more than one reported value (i.e. two or more studies reported frequency at the same time post-injury) were weighted based on sample size. For studies where baseline assessment was conducted prior to or at one month post-injury, mean weighted frequencies were 46.6% (SD = 32.7, n = 206) Ponsford et al., 2012) , 45.9% (SD = 24.8, n = 637) Ponsford et al., 2012; Norrie et al., 2010; Yang et al., 2009) , 17.3% (SD = 13.6, n = 325) Meares et al., 2011; Yang et al., 2009) , 45.2% (SD = 29, n = 230) van der Naalt et al., 1999; McLean et al., 1993) , 30.5% (SD = 11.7, n = 830) Lundin et al., 2006; Mickeviciene et al., 2004; Norrie et al., 2010) , 32.4% (SD = 7.3, n = 269) van der Naalt et al., 1999) and 37.4% (SD = 8.1, n = 354) van der Naalt et al., 1999; McLean et al., 1993) for two days, six days-one week, two weeks, one month, three months, six months and one year post-injury, respectively. The number of studies contributing to the mean for a particular time point ranged from two studies for two days and six months post-injury to seven studies for three months post-injury (Fig. 3a) .
For studies with baseline assessment after one-month postinjury, just one mean weighted frequency value was obtained for one time point, 22.8% (SD = 5.4, n = 172) Hou et al., 2012) at six months post-injury. Two studies contributed values for calculation of this mean. The remaining time points comprised single studies and therefore one frequency value (Fig. 3b) .
The course of fatigue, by injury severity
When fatigue frequency calculations were stratified by injury severity, mean weighted frequencies could only be obtained for the mild TBI group with baseline assessments conducted less than or at one month after injury. The frequencies of fatigue were 46.6% (SD = 32.7, n = 206) Ponsford et al., 2012) , 45.9% (SD = 24.8, n = 637) Ponsford et al., 2012; Norrie et al., 2010; Yang et al., 2009) , 17.3% (SD = 13.6, n = 325) Meares et al., 2011; Yang et al., 2009 ) and 27.8% (SD = 7.8, n = 763) Ponsford et al., 2012; Lundin et al., 2006; Meares et al., 2011; Mickeviciene et al., 2004) for two days, six days-one week, two weeks and three months post-injury, respectively. The number of studies contributing to the means ranged from two studies for two days post-injury to six studies for three months. The mild TBI group with baseline assessments performed after one-month post-injury and mild to moderate and mixed groups all had one contributing study each. The studies featuring moderate to severe TBI did not report fatigue frequencies.
For the purpose of comparison of fatigue frequencies between mild TBI and other severities, studies reporting frequencies in samples of mild to moderate and mixed severities of TBI were grouped. Mean frequencies were 66.3% (SD = 8.5, n = 147) McLean et al., 1993) and 46.2% (SD = 1, n = 162) McLean et al., 1993) for one month and one-year post TBI, respectively. The two contributing studies had baseline assessment performed within the first month post-injury.
Fatigue severity
In two studies using the FSS, the sample mean scores at 12 months were 3.20 ± 1.39 and 2.9 ± 1.6 . One study, using an alternate FSS scoring system , reported similar fatigue severity. In the two studies that utilized the SF-36 vitality subscale and the SF-36 vitality subscale version 2, the mean scores at one year post-injury were 62.11 ± 20.18 ) and 49.6 ± 11.83 and 52.3 ± 12.22 for two TBI subgroups (De ). Other researchers who utilized the same standardized scales could not be compared on the basis of their measurement of fatigue at different time points, or missing data on scores (Table 5) .
Impact of fatigue after TBI
One study where baseline assessment took place prior to one month post-injury and one with baseline assessment at three months post-injury investigated consequences of fatigue. Table 4 shows lists the consequences significantly associated with fatigue. One study of moderate quality looked at the relationship of fatigue with persistent post-concussive symptoms , and one of fair quality looked at its association with the Glasgow outcome scale-extended (GOSE) total score .
Persistent post-concussive symptoms: Fatigue severity at one week and three months predicted persistent post-concussive symptoms at three months and six months, respectively, controlling for litigation, psychological/neurological disorders, and substance abuse (Table 4) .
GOSE total score: An association with the GOSE score was found in Sigurdardottir et al.'s study controlling for education, PTA, intracranial pathology and relevant psychological tests in multivariate regression analysis models. In the mild TBI group, the FSS total score was a significant predictor of GOSE score (R 2 = 0.47; p < .001), explaining 23% of the total variance in GOSE score at one year post-injury. Similar results were obtained for the moderate to severe TBI group (R 2 = 0.58; p < .001) ( Table 4) .
3.12. Associations of fatigue with other clinically important variables 3.12.1. Studies with baseline assessment up to one month post-injury Lundin et al. (2006) found poor memory, sleep disturbance and fatigue to be most commonly reported within their sample, with early symptom overlap correlated with later results. Similarly, Meares et al. (2011) found symptom overlap of fatigue, insomnia, and irritability at five days and three months post-injury, with some participants recovering from and others developing the symptoms as time went on.
Norrie et al. found a significant increase in the percentage of those with fatigue reporting depression and/or anxiety, both symptoms over the cut off indicating mild severity, at six months after injury, compared with reports at three months. This increase coincides with a leveling off of fatigue percentages. As fatigue becomes persistent, psychological factors such as anxiety and depression tend to worsen .
Ponsford et al.'s mTBI group reported significantly poorer general health, vitality, and mental health, as demonstrated by their scores in the corresponding subscales of the SF-36, compared to trauma controls; however, a similar pattern was observed when participants completed the same scales but with regard to their pre-injury status. The authors highlighted the importance of documenting pre-injury status in TBI studies.
Studies with baseline assessment after one month post-injury
Bushnik et al., investigating changes in fatigue from 6 to 12 months post-injury, reported a significant change in the Pittsburgh sleep quality index (PSQI) scores: where fatigue increased, PSQI scores were higher compared to cases where there was no change or decreased fatigue. There were no other significant group differences on the pain VAS, disability rating scale, neurobehavioral functioning inventory motor subscale, the Craig handicap assessment and reporting technique (CHART) cognitive independence, and CHART occupation . The authors suggested that, for TBI individuals who complain of fatigue, assessing sleep quality would be a high-yield correlate and possibly treatable with behavioral and/or medication interventions. Kempf et al. reported no associations between fatigue parameters and TBI severity, alcohol intake at time of injury, nor with sleep duration, education, age or gender. They did, however, find a moderate correlation between FSS and depression symptoms assessed with the Beck depression inventory (BDI) (r = 0.46, p = 0.001), and with anxiety symptoms assessed with the Hospital anxiety and depression scale (HADS) (r = 0.37, p = 0.007). They also reported coincidence of fatigue and excessive daytime sleepiness .
Medications, drugs and alcohol
Seven of the 22 studies listed regular intake of psychoactive drugs and/or history of drug or substance abuse prior to TBI in study exclusion criteria Norrie et al., 2010; McLean et al., 1993; Jha et al., 2008; Kaiser et al., 2010; Khateb et al., 2005; Schoenberger et al., 2001) . One study excluded persons taking medications that cause sleep/wake disturbances, however, details were not provided . Eight of the 22 studies did not report on use of medications/illicit drugs/alcohol by participants prior to or over the course of the study De Leon et al., 2009; Lundin et al., 2006; Yang et al., 2009; Sundstrom et al., 2007; Hutchinson et al., 2009; Gemmell and Leathem, 2006; Hou et al., 2012) . Nine studies reported a variation of data. Bushnik et al. (2008a) reported use of alcohol by 62% prior to the first assessment, with 19% identified as drug users and heavy and/or binge drinkers. Sigurdardottir et al. (2009) described, at the second assessment, use of alcohol more than once per month in 48% of mild to moderate injured persons and in 27% of the severely injured. Use of alcohol and/or drugs more than two or three times per week was reported by 17%, and more than four times per week by 7% of participants ). Ponsford et al. (2012) included breath alcohol levels at recruitment exceeding 0.05 mg/L of alcohol, influence of illicit drugs at injury, history of significant drug/alcohol abuse affecting daily functioning in their exclusion criteria. Those reporting alcohol or cannabis use, and who did not have cognitive difficulties pre-injury were not excluded. The study reported frequency of lifetime substance abuse to be 31.3% in the mTBI sample and frequency of substance abuse in the previous three months to be 6.7% . Meares et al. (2011) reported use of opioids/opiates by 59.7% across the first and second assessments, and use of marijuana was reported in 24.4% of mTBI cases. In Driver and Ede's study, 61.1% reported intake of selective serotonin reuptake inhibitors (SSRIs). One study indicated changes in medication regimes of participants with flexyx neurotherapy system treatment, but did not clarify the nature of the changes ).
Discussion
Factors associated with fatigue
When we sought evidence of a temporal relationship between clinically important factors and fatigue we focused on: (1) TBI population characteristics (e.g. time since injury, severity of injury, comorbid conditions, etc.) and (2) our outcome of interest (i.e. fatigue) -its frequency, severity, and definition, with the goal of obtaining a set of risk factors that can be used for prognosis. Table 4 presents a descriptive summary of the available evidence. In summary, several potential risk factors for fatigue in TBI have been investigated, including those related to demographics and socioeconomic status, injury severity, medical comorbidities, baseline fatigue levels, genetic makeup, and physical and cognitive independence.
Fatigue at baseline, occurring at any time from injury through the acute care course, was found to be a primary predictor of symptom chronicity in TBI of varying severities . Baseline fatigue was found to be one of the most powerful predictors of fatigue at follow-up (De Norrie et al., 2010) . Other studies on chronic fatigue syndrome show similar associations between long-lasting fatigue and fatigue at baseline (Cairns and Hotopf, 1997; Nisenbaum et al., 2003; Kato et al., 2006) , concurrent with the results of another study, where pre-stroke fatigue was reported to be related to fatigue in the acute phase after stroke (Lerdal et al., 2011) . Despite reports of an impact of baseline fatigue on outcome at follow-up, the clinically important "critical values" of fatigue severity and duration following brain injury are not established. Future research should record frequent and specific data in investigation of the etiology of pre-morbid and baseline fatigue, and control for multiple factor interactions, in addition to the magnitude of effect attributable to individual factors in analyses. More attention needs to be paid to patients with intensive fatigue at baseline, as it is related to prognosis.
Female sex, education, GCS score, and alcohol use at the time of injury were reported to have no associative value for fatigue severity in a study of mild TBI . Differences in severity and frequency of fatigue between men and women have been observed after stroke (Lerdal et al., 2011) , depression (Khan et al., 2002) , obstructive sleep apnea (Chervin, 2002) , heart disease (Ekman and Ehrenberg, 2002) , and cancer (Miaskowsky, 2004) , with females more often reporting fatigue than their male counterparts. Sex-related differences in fatigue were investigated in just one reviewed study, and further research is warranted. Other factors associated with fatigue frequency and severity at follow-up, reported reviewed studies, included carriage of the APOE 4 allele , counseling for mental health, medical disability, specific marital status (i.e. widowed, divorced, or separated), and involvement in litigation . The APOE 4 allele in persons with TBI was previously reported to be linked to an increased risk of Alzheimer's disease (Jellinger et al., 2001) . In a study of the general population (O'Hara et al., 2005) , a relationship between sleep apnea (SA) and dementia through the APOE 4 allele was observed. Sleep apnea, highly prevalent in the TBI population (Mollayeva et al., 2013b) , may explain the link between the APOE 4 allele and fatigue and dementia. While studies to date have outlined the separate relationships between TBI, SA, fatigue, the APOE 4 allele, and dementia, their complex interaction requires rigorous study.
Frequency, severity and course of fatigue in TBI
This systematic review underlines the variation in frequency of fatigue that exists after TBI, regardless of studies' set time zeros (Fig. 3a and b) . Changes in the proportion of participants reporting fatigue from the start of the study to its completion also varied, some reporting gradual or abrupt increases or decreases, and others reporting frequency fluctuation over the course of study. A steep drop in frequency was observed at two weeks post-injury, with most of the contributing studies featuring mTBI patients. This drop might be explained by the current clinical management of mTBI, including the prescription of a rest period of at least two weeks after injury. As fatigue is influenced by the degree of physical and/or cognitive exertion, as well as the amount of rest one has received, it is possible that a mildly injured person, after completing a course of rest, would not perceive fatigue; however, their fatigue could resume when they return to regular duties and responsibilities. Unchanged frequencies were commonly associated with RCTs with close follow-up times (e.g. 1-3 months). The observed variation in the natural history of fatigue post TBI may be related to the tools utilized by the different researchers, and the constructs those tools measured. Respondents' interpretations of the construct of fatigue, as well as its complex underlying pathogenesis with different mechanisms inter-related at different time points, are expected to influence the results obtained.
The dimensions assessed in the studies utilizing fatigue scales or single items included momentary perception, chronic perception, the impact of fatigue on function, rating of tiredness, dimensions of fatigue (i.e. mental, physical), or severity of the fatigue (Supplementary file 3). The various measures also attach different weights to different aspects of fatigue, depending on the conceptualization of fatigue by the developer (Chaudhuri and Behan, 2004) . In some studies, fatigue was conceptualized as a one-dimensional entity in which persons are deemed either fatigued or not fatigued based solely on their perception of the experience at the time of completion.
Interpretation of scale items by the respondent can be significantly confounded by the association of fatigue with other symptoms, particularly apathy, excessive sleepiness, depression, lack of motivation, anxiety, litigation and cognitive dysfunction. In TBI patients, fatigue was reported to be associated with depression; moreover, in the regression analyses in one reviewed study , the severity of fatigue was predicted by depression. Kempf et al. (2010) reported that fatigue and excessive daytime sleepiness coincided in their sample. Excessive daytime sleepiness may be an indicator of central nervous system (CNS) pathology due to brain injury (i.e. hypocretin/orexin deficiency), as well as related to quantity and quality of sleep (Mollayeva et al., 2013b; Baumann, 2012; Nardone et al., 2011; Mathias and Alvaro, 2012; Siebern and Guilleminault, 2012) . While Kempf et al. (2010) studied and did not uncover a relationship between fatigue and sleep duration, quality of sleep was not investigated. A number of sleep disorders (i.e. sleep-related breathing disorder, periodic leg movement disorder, etc.) highly prevalent post-TBI (Nardone et al., 2011; Mollayeva et al., 2013c) are characterized by frequent arousals, which generally result in fragmented sleep, which can produce daytime sleepiness (Stepanski, 2002) . Bushnik et al. (2008a) suggests assessment of sleep quality as a valuable measure when studying TBI patients with fatigue complaints.
Symptoms of fatigue and cognitive dysfunction have been reported to overlap in persons with TBI (Johansson et al., 2009; Zaben et al., 2013) . This can potentially influence accuracy of selfreport, as a person with cognitive dysfunction may not be able to fully grasp the changes in fatigue since their injury, as well as its impact on daily functioning, as required in completion of certain self-report measures. Bushnik et al. (2008a) reported that a subset of individuals who experienced significant increase in fatigue over the first two years post-injury demonstrated poorer outcomes in cognition, motor symptoms, and general functioning compared to those with decreased or stable fatigue . A separate study had similar findings -subjective mental fatigue following brain injury was correlated with objectively measured information processing speed (Johansson et al., 2009) . In other literature again, post-traumatic conditions such as hypopituitarism have been reported to have a wide range of manifestations, including fatigue, myopathy, cognitive difficulties, depression, and behavioral changes (Zaben et al., 2013) . The same degree of fatigue, therefore, will not be perceived with equal intensity by persons with different comorbid conditions or fatigue etiology. Moreover, fatigue manifestation is thought to be differentially modulated by a variety of factors within and between TBI persons with time. Distinguishing fatigue as a result of TBI from fatigue associated with comorbid conditions (i.e. depression, pain, anxiety, apathy, sleep dysfunction, medication effect, etc.) is a complicated task. As such, future research should consider use of additional measures for common comorbidities when assessing PTF.
Fatigue severity (i.e. mean FSS scores) was higher in persons with TBI than previously reported for healthy adults (2.3 ± 0.7) (Krupp et al., 1989) , but lower than those in patients with systemic lupus erythematosus (SLE) (4.7 ± 1.5) (LaChapelle and Finlayson, 1998) , rheumatoid arthritis (4.2 ± 1.2) (Krupp et al., 1989) and psoriatic arthritis (6.9 ± 2.4) (Cella et al., 2005) . Bushnik et al. (2008a) reported FSS scores obtained at 6, 12, and 18-24 months postinjury, all falling within the score range for non-fatigued control subjects (Table 5) .
Studies differed in reports of fatigue severity over time, with some noting changes with and others stability. It is plausible that time since injury is a determinant of effectiveness of coping strategies and thereby perception of symptom severity. A study of persons with chronic fatigue syndrome reported better adaptive coping strategies with longer disease duration. Alternatively, spinal cord injury patients showed no changes in coping styles over time (Craig et al., 1994) . Future longitudinal studies of coping by persons who sustained a TBI may provide greater insight. Age differences between samples should also be considered. In a study of fatigue in the general population, Cella et al. (2002) reported that people older than 50 years in the described more severe fatigue than the younger population. The mean age in samples of reviewed studies reporting fatigue severity ranged from 20.1 ± 1.8 ) to 45.7 ± 10.8 (Gemmell and Leathem, 2006) . We did not observe relationship between age and severity of reported fatigue, however (Table 5) .
Other factors related to the discussion of fatigue severity have to do with the impact of brain injury on a person's ability to perform pre-morbid duties and manage responsibilities. Diminished activity due to changes in lifestyle, with subsequent loss of muscle tone and weakness, or muscle weakness due to neurological impairment, can result in greater fatigue perception associated with mild activity (Chaudhuri and Behan, 2004) .
Consequences of fatigue in TBI
Possible consequences of fatigue emerged in the studies reviewed. Fatigue severity one week post-injury was associated with persistent post-concussive symptoms at three months , and the FSS total score was significantly associated with the GOSE score for all severities of TBI ). Post-concussion syndrome (PCS) itself refers to a group of symptoms, including headache, dizziness, fatigue, and affective and cognitive changes, that may be reported by patients after TBI (McAllister, 1994) . Thus, it is possible that severe post-concussive symptoms that are not resolved over a short period (i.e. three months), influence fatigue outcomes. The fact that the GOSE, the "gold standard" for assessing patient outcomes after TBI (Shukka and Devi, 2011) , was affected by baseline fatigue severity across all injury severities at one year post-injury is significant, as it suggests that fatigue can be long lasting, with a low likelihood of resolution. Consequently, diagnostic efforts that consider diverse factors and comorbid conditions (Figs. 1 and 2 ) should be implemented in the very early stages post-injury.
Medication effects
CNS depressants can cause or increase fatigue (Liska, 2008) . In the reviewed studies, just seven included their use in the exclusion criteria. Nine studies provided some information on the use of medications/illicit drugs/alcohol by participants prior to or over the course of the study. None, however, considered the potential confounders in this relationship. Reported use of alcohol by 62% of participants in the period before the first assessment, with 19% identified as drug users, heavy and/or binge drinkers is striking . Ethyl alcohol is a CNS depressant, and the injured brain is particularly sensitive to its effects at the highest centers (i.e. speech, thought, cognition) and lower brain functions (i.e. spinal cord reflexes, respiration), as the dosage increases (Liska, 2008) . Norrie et al. (2010) reported that alcohol intake prior to the injury was not correlated with fatigue severity at three months after injury, as measured by FSS, however, the researchers did not report alcohol intake of participants throughout the course of the study. This is significant, as studies in the general population have reported fatigue to be the most severe hangover symptom (Penning et al., 2012; Rohsenow et al., 2007) .
Intake of SSRIs was reported by 61.1% of the participants in Driver and Ede's study. While this class of medications is a first line of treatment for depression following TBI (World Health Organization, 2002) , some drugs within this class (i.e. fluoxetine and paroxetine) may be problematic due to their adverse effects, including those related to fatigue and cognitive function (Schmitt et al., 2001) . Another reviewed study reported use of opioids/opiates by 59.7% of participants . Opium alkaloids are narcotic analgesics and narcosis is defined by depression of the CNS leading to analgesia, drowsiness, changes in mood, mental clouding, lethargy, apathy and subsequent unconsciousness (Shukka and Devi, 2011) . While currently there is no strong evidence directly relating physical and mental fatigue in TBI to side effects of opiates and opiods (Chapman, 2002; Leong and Royal, 2004) , data on its safety for chronic use is also lacking (Rhodes, 2012) . While our discussion of medication effects and fatigue in TBI is limited, given the complexity of the fatigue symptom and incomplete data available, future research should consider such effects, as the potential of medications to cross the blood-brain barrier and mimic neurological deficits and cause or exacerbate PTF, is real (Daneman, 2012; Maher et al., 2011) .
To complete our discussion, we follow with recommendations for future research in the field of fatigue and TBI. As mentioned, along with the confounding effects and selection bias, the method by which fatigue was measured contributed significantly to the variation observed in results. The words that one uses to define fatigue can be vague, especially if the reporter (i.e. patient with TBI) has additional complaints related to constructs such as excessive sleepiness and impaired alertness. As such, separate assessment of each construct is preferable. When featured as one item within a self-report measure, even when spontaneously endorsed and ranked as the most important symptom, patients may rank their fatigue experience understanding it as being exhausted, tired, weak, while others may feel physically exhausted but mentally alert. As such, a single question hampers interpretation of the score. While it is not always the case that multi-item instruments are more valid than a single item, especially if the global opinion of the patient is of interest, adding one global item about the construct to a multi-item symptom measure in the future can help in the interpretation and validation of the instrument in the population of interest. This is particularly relevant to the study fatigue in the TBI population as, despite the number of multi-item standardized measures that have been utilized, only the FSS, the MFIS and the SF-36 have been partially validated against other fatigue measures in a TBI sample. Moreover, there are no psychometric data on the responsiveness of these measures, implying limited understanding of how much error exists when measuring changes in fatigue over time. Currently, the field of TBI requires further testing of existing self-report measures whose psychometric properties were described in other target populations, focusing on measures pertaining to the multidimensional etiology and state of PTF.
None of the studies reviewed applied technologies (i.e. electroencephalography, functional magnetic resonance imaging, magnetic resonance spectroscopy, regional brain volumes, motor evoked potential, etc.) or markers of physiological processes (i.e. function of hypothalamic-pituitary-adrenal axis, autonomic nervous system response, metabolic processes, immune system response, etc.) to study the fatigue experienced by individuals with TBI. The latter is important, as research has shown that the resting pulmonary and cardiorespiratory function in patients with TBI is compromised (Jankowski and Sullivan, 1990) . This can be related to deconditioning as a result of a more sedentary lifestyle (Giordon et al., 1998) . In a study of maximal physiologic responses during exercise in patients with moderate to severe TBI at 17.2 ± 17 months after injury, several weeks of an exercise training program reduced physiologic fatigue (Bhambhani et al., 2005) . Others reported that aerobic fitness in individuals with TBI enhanced cognition and improved mood (Carroll et al., 2004b; Cassidy et al., 2014) . This is extremely important as fatigue perception ratings were found to be higher in patients with depression . Again another study (Jankowski and Sullivan, 1990) reported that a 16-week circuit training program of moderate intensity and prolonged duration increased TBI patients' oxidative capacity and muscular endurance and the index of physiologic fatigability was shown to be useful for the assessment and evaluation of individuals with TBI. Similarly, in a reviewed study by Driver and Ede (2009) fatigue elimination was reported after an eight-week group aquatic program, with no changes in fatigue in the control group. Thus, further study that accounts for the physiologic, objective performance, and/or homeostatic changes with regard to increased perception/manifestation of fatigue after brain injury is within the top priorities for future research.
Limitations
We acknowledge heterogeneity in the primary studies with respect to sample characteristics (i.e. age, injury/localization of injury, time since injury) and fatigue definitions. Another concern related to the reviewed studies, largely of "moderate" quality, is that severe TBI is underrepresented in the inception cohorts and the evidence for the second and third research questions of this review was based largely on mild TBI cohorts. Additionally, the majority of the patients in the studies were men, which limits the precision of estimates of predictors and consequences for fatigue in severe TBI, especially for women (Table 2) .
Most studies focused largely on the fatigue symptom; the strength and significance of associations with other factors (e.g. sleep, other medical conditions, medication use or clinically important symptoms such as alertness, sleepiness) were often not reported. Thus, the roles of other factors could be underestimated in this review.
The focus of this review was the natural history of fatigue in patients with TBI. To be consistent with our protocol (Mollayeva et al., 2013a) , results from all selected longitudinal studies were used to address the first research question (i.e. natural history of fatigue). Since baseline fatigue assessment was performed at different times since injury, we attempted to mitigate zero-time effect by reporting results with baseline assessments up to one month post-injury and after one month, separately. Nevertheless, generalizability of results remains unclear due to inadequate reporting of selection criteria, poor control of confounding effects, and attrition.
There are limitations to the presented data on fatigue measures used in the reviewed studies (Supplementary file 3) . For conciseness, properties of the measures, specifically those related to psychometrics, were not reported in great detail. Despite attempts to include all relevant articles for their use in the TBI population, it is possible studies were missed.
All articles included in this review are peer-reviewed. As such, there is possibility for publication bias. Finally, the inclusion of only English language articles could affect the generalizability of our findings.
Pitfalls and controversies
Despite the existence of clinical criteria for the diagnosis of PCS, the self-reported nature of nonspecific symptoms such as fatigue can be confounded by other factors (i.e. psychological distress, pain, depression, etc.). This may be particularly apparent in patients with insurance claims that are being disputed. Their need to provide proof of disability may magnify fatigue symptoms and result in controversy about whether symptoms are indicators of brain injury or are of behavioral origin (Carroll et al., 2004b; Cassidy et al., 2014) . Also, fatigue as a symptom is nonspecific to TBI. Fatigue appears with other diagnostic labels in other clinical specialities -for example fibromyalgia, chronic fatigue syndrome, endocrine disorders, and patients with psychiatric illness Cairns and Hotopf, 1997; Nisenbaum et al., 2003; Kato et al., 2006; Lerdal et al., 2011; Cassidy et al., 2014) . Previous systematic reviews on the epidemiology, diagnosis, prognosis, treatment and costs of mTBI raised the issue of specificity of self-reported symptoms such as headache, fatigue, cognitive deficits to mild TBI (Carroll et al., 2004b; Cassidy et al., 2014) , with the recommendation to replace the term post-concussion syndrome with the term post-traumatic symptoms.
The reviewed studies allowed comparison of fatigue severity only between mild TBI participants and controls, limiting our discussion to a single severity of injury. While concussed athletes had more fatigue compared to healthy controls at one week postinjury, that was not the case at two weeks . Similarly, fatigue was greater in the mild TBI group compared to controls shortly after the injury, but not at three months post-injury in Lundin et al.'s and Meares et al.'s samples. De Leon et al. (2009) found that fatigue severity at the one year follow-up was not associated with the type of injury (i.e. mild TBI vs. non-head injury) in a fully adjusted model. Pair-wise comparisons showed lower fatigue scores in the mild TBI group at 12 months compared to the other injury group. Contrariwise, Sundstrom et al. (2007) reported that their mild TBI group had less fatigue pre-injury and more post-injury compared to age-, sex-, and education-matched controls.
Given this lack of specificity of the fatigue symptom, this topic is perplexing and time consuming. An accurate investigation of fatigue in TBI must begin with a clear definition of the most common symptomatic descriptor, "feeling fatigued". Next, the cause of fatigue must be determined and a diagnosis established. Although the pathophysiology of fatigue after TBI is still poorly understood, the goal is to determine whether the fatigue is caused by a correctable factor (i.e. depression, endocrine dysfunction, deconditioning, poor sleep, etc.) so that interventions are applied appropriately. Fig. 4 illustrates the proposed algorithm for study of PTF.
Conclusions
Fatigue is a common symptom post TBI. Its frequency may change over time, but fatigue can persist years after the injury. This may be related to pre-morbid/early fatigue, mental health issues, other medical conditions, and ongoing societal stressors. Clinicians seeing patients with TBI at the acute stages post-injury with high early fatigue intensity, mental health issues, and litigation involvement should be aware that these may be associated with the development of persistent post-concussive symptoms. The available evidence on the associative value of these factors, as well as the consequences of fatigue, is currently not very strong, as we found just three cohort studies addressing these issues. More research is needed to establish associations between fatigue and other clinically important pre-and post-morbid variables (i.e. sleep dysfunction, depression, physical and cognitive impairments, other medical/neurological disorders), and their impact on outcomes post-injury. Medication effects, personal factors such as coping ability, physical deconditioning, stress level, and time factors should also be investigated. This is particularly important for translation of research into clinical practice, in order to address risk factors and course of condition. An international consensus, similar to the National Institutes of Health and developed for rehabilitation in TBI in 1999 (Consensus Conference, 1999) advising on how best to study clinically important symptoms such as fatigue in TBI, is of utmost importance. In particular, there needs to be a consensus on the definition of pathological PTF, set times for baseline assessment, recognizing the challenges in studying the symptom in moderate-severe brain injury at time zero, clinically relevant period of follow-up, acceptable attrition rates to ensure representative samples, and validated measures of outcome, all of which can reduce heterogeneity of results. What will be left to focus on then is the variety of lesions from TBI (i.e. white or gray matter, specific tract damage, lesion volume, localization of injury, etc.) and inter-individual variability in perception and multifactorial fatigue etiology, which may find study of individual patients best. A caveat to this point is that case-reports of patients whose symptoms and clinical course do not fit the typical picture, may lead to scientific progress in the understanding of and appreciation for the complexity of the fatigue symptom post TBI (Yennurajalingam and Bruera, 2007) .
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